Prostaglandin-E Urinary Metabolite (PGE-M) as a Predictor of Acute Appendicitis in Children
NCT ID: NCT07008092
Last Updated: 2025-06-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
100 participants
OBSERVATIONAL
2025-06-02
2026-05-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The study will be conducted over 12 months and will include 100 children aged 5 to 17 years presenting with acute abdominal pain. In addition to routine laboratory tests, urinary PGE-M levels will be analyzed. The study involves minimal risk to participants
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Diagnostic Importance of the Circulating Human Leucine-rich α-2-glycoprotein in Acute Appendicitis in Pediatric Patients
NCT05093660
A Novel Appendicitis TriMOdal Prediction Score (ATMOS) for Acute Appendicitis in Pregnancy: a Retrospective Observational Study
NCT05202483
Plasma Sodium: a Predictor of Perforation in Acute Appendicitis. (The NAP-study)
NCT04806789
Cardiovascular Risk After Preeclampsia
NCT05277233
At High-risk for Pre-eclampsia After Assisted Reproductive Technology
NCT05746793
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The aim of this study is to determine whether PGE-M levels are elevated in children with acute appendicitis and whether this biomarker could be used in the diagnosis of acute appendicitis.
The planned duration of the study is 12 months, with a projected sample size of 100 participants.
Inclusion criteria: Children aged 5 to 17 years presenting with acute abdominal pain and signs and symptoms suggestive of acute appendicitis, without significant comorbidities.
Exclusion criteria: Children outside the specified age range, those with a previously diagnosed chronic or malignant disease, a history of abdominal surgery, or pregnancy.
For each child included in the study, demographic data, clinical characteristics, laboratory and diagnostic test results, intraoperative findings, and discharge diagnoses will be recorded. Since the child is already indicated for surgery or hospital admission regardless of study participation, there are no significant risks associated with participation in this study-apart from potential, but rare, complications related to peripheral venous blood sampling (e.g., hematoma or discomfort).
For the purposes of the study, a peripheral venous blood sample will be collected (on the day of surgery or hospital admission) to analyze laboratory parameters including leukocyte count, C-reactive protein, and neutrophils. Additionally, a urine sample will be collected to determine the levels of prostaglandin E urinary metabolites (PGE-M) and creatinine
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Acute appendicitis with rupture
Blood specimen collection
Blood specimen collection for analysis of C-reactive protein, white blood cell count and neutrophile count.
Urine collection
Urine sample collection for analysis of creatinine and prostaglandin E urinary metabolites
Acute appendicitis without rupture
Blood specimen collection
Blood specimen collection for analysis of C-reactive protein, white blood cell count and neutrophile count.
Urine collection
Urine sample collection for analysis of creatinine and prostaglandin E urinary metabolites
Control group
Patients with abdominal pain in which acute appendicitis has been ruled out as a cause
Blood specimen collection
Blood specimen collection for analysis of C-reactive protein, white blood cell count and neutrophile count.
Urine collection
Urine sample collection for analysis of creatinine and prostaglandin E urinary metabolites
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Blood specimen collection
Blood specimen collection for analysis of C-reactive protein, white blood cell count and neutrophile count.
Urine collection
Urine sample collection for analysis of creatinine and prostaglandin E urinary metabolites
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* children with clinical signs of acute appendicitis
Exclusion Criteria
* children who had previous abdominal surgery
* pregnancy
5 Years
17 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
KBC Split
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Tomislav Žuvela
Doctor of Medicine, Plastic surgery resident
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital of Split
Split, , Croatia
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2181-147/01-06/LJ.Z.-25-02
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.